NASDAQ:PTIXW

Protagenic Therapeutics (PTIXW) Stock Price, News & Analysis

$0.02
0.00 (-13.47%)
(As of 04/25/2024 ET)
Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.04
52-Week Range
$0.00
$0.04
Volume
730 shs
Average Volume
4,684 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Protagenic Therapeutics

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

PTIXW Stock Price History

PTIXW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive PTIXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:PTIXW
Web
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Garo H. Armen Ph.D. (Age 71)
    Co-Founder & Executive Chairman of the Board
  • Dr. Alexander Kenneth Arrow C.F.A. (Age 53)
    M.D., CFO & Secretary
    Comp: $150k
  • Dr. Andrew Slee Ph.D. (Age 74)
    Chief Operating Officer
  • Dr. Robert Benjamin Stein M.D. (Age 73)
    Ph.D., Chief Medical Officer & Director

PTIXW Stock Analysis - Frequently Asked Questions

How have PTIXW shares performed in 2024?

Protagenic Therapeutics' stock was trading at $0.0150 at the start of the year. Since then, PTIXW shares have increased by 49.8% and is now trading at $0.0225.
View the best growth stocks for 2024 here
.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PTIXW) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners